Cargando…
Concordance assessment of Watson for Oncology in breast cancer chemotherapy: first China experience
BACKGROUND: IBM Watson for Oncology (WFO) is an artificial intelligence cognitive computing system that provides confidence-ranked, evidence-based treatment recommendations for cancer. We examine the level of agreement for breast cancer chemotherapy between WFO recommended and clinical use in a larg...
Autores principales: | Pan, Hong, Tao, Jing, Qian, Mengjia, Zhou, Wenbin, Qian, Yi, Xie, Hui, Jing, Shengqi, Xu, Tingyu, Zhang, Xin, Dai, Zuolei, You, Mingliang, Liu, Yun, Liu, Xiaoan, Wang, Shui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798315/ https://www.ncbi.nlm.nih.gov/pubmed/35116771 http://dx.doi.org/10.21037/tcr.2019.01.34 |
Ejemplares similares
-
Concordance Between Watson for Oncology and Multidisciplinary Teams in Colorectal Cancer: Prognostic Implications and Predicting Concordance
por: Mao, Chenchen, et al.
Publicado: (2020) -
Concordance Study Between IBM Watson for Oncology and Real Clinical Practice for Cervical Cancer Patients in China: A Retrospective Analysis
por: Zou, Fang-wen, et al.
Publicado: (2020) -
Concordance of Treatment Recommendations for Metastatic Non-Small-Cell Lung Cancer Between Watson for Oncology System and Medical Team
por: You, Hai-Sheng, et al.
Publicado: (2020) -
Concordance Between Watson for Oncology and a Multidisciplinary Clinical Decision-Making Team for Gastric Cancer and the Prognostic Implications: Retrospective Study
por: Tian, Yulong, et al.
Publicado: (2020) -
Real world study for the concordance between IBM Watson for Oncology and clinical practice in advanced non‐small cell lung cancer patients at a lung cancer center in China
por: Yao, Shuyang, et al.
Publicado: (2020)